✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Suvorexantis the generic ingredient in one branded drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Suvorexant has seventy-six patent family members in thirty-seven countries.
One supplier is listed for this compound.
Summary for suvorexant
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||58|
|What excipients (inactive ingredients) are in suvorexant?||suvorexant excipients list|
|DailyMed Link:||suvorexant at DailyMed|
Recent Clinical Trials for suvorexant
Identify potential brand extensions & 505(b)(2) entrants
|Stanford University||Phase 2|
|National Institutes of Health (NIH)||Phase 2|
|Baylor College of Medicine||Phase 3|
Pharmacology for suvorexant
|Drug Class|| Orexin Receptor Antagonist |
|Mechanism of Action||Cytochrome P450 3A Inhibitors |
Orexin Receptor Antagonists
|Country||Patent Number||Title||Estimated Expiration|
|Japan||5335758||See Plans and Pricing|
|Japan||2015518867||オレキシン受容体アンタゴニストの固形剤形||See Plans and Pricing|
|Russian Federation||2009125024||СОЕДИНЕНИЯ ЗАМЕЩЕННЫХ ДИАЗЕПАНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ ОРЕКСИНОВЫХ РЕЦЕПТОРОВ||See Plans and Pricing|
|South Korea||20150014940||SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST||See Plans and Pricing|
|Serbia||52617||SUPSTITUISANA JEDINJENJA DIAZEPANA KAO ANTAGONISTI RECEPTORA ZA OREKSIN (SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS)||See Plans and Pricing|
|Japan||4675427||See Plans and Pricing|
|Israel||198825||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.